What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?
Nat Biotechnol
.
2023 Jun;41(6):878-879.
doi: 10.1038/s41587-023-01817-5.
Authors
Jennifer Y Kim
1
,
Emily Botto
2
Affiliations
1
Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Boston, MA, USA.
[email protected]
.
2
Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Boston, MA, USA.
PMID:
37316731
DOI:
10.1038/s41587-023-01817-5
No abstract available
MeSH terms
Diversity, Equity, Inclusion*
Workforce